Papers

2

Total Citations

31

H-Index

2

About

Adam Sacarny is a health economist whose research illuminates how technology, policy, and market forces shape healthcare delivery and outcomes. His most-cited work, "Technology Adoption and Market Allocation: The Case of Robotic Surgery" (2022, 26 citations), examines the rapid diffusion of robotic surgery for prostate cancer, revealing how hospital adoption of this costly technology reshapes patient flows and market competition. This study provides critical evidence on the unintended consequences of technology adoption in healthcare markets, showing that hospitals investing in robotic systems attract healthier, better-insured patients—potentially exacerbating disparities in access to care. Sacarny’s broader research portfolio spans physician behavior, prescription drug markets, and the impact of Medicare payment reforms. His work is characterized by rigorous causal inference methods and a focus on real-world policy implications. With citations accumulating across health economics and health policy literatures, Sacarny’s findings inform ongoing debates about technology regulation, payment reform, and equitable healthcare delivery. His scholarship is essential reading for researchers and students interested in how economic incentives and technological change interact to shape modern medicine.

Research Focus

Key Achievements

2
H-Index
2
Papers
31
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Technology adoption and market allocation: The case of robotic surgery
26 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: National Bureau of Economic Research, RAND Corporation

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago